NorthCore Life Sciences is approved for IPO on the ChiNext board, focusing on the research, development, and sales of innovative medical devices for precise diagnosis and treatment of cardiovascular diseases.

date
18/07/2025
According to the Securities Times, on July 18th, Shenzhen Beixin Life Science and Technology Co., Ltd. (Beixin Life) passed the listing committee meeting of the Shanghai Stock Exchange's Sci-Tech Innovation Board (STAR Market) IPO. The sponsoring institution is CICC, and it plans to raise 952 million yuan.